Helana Shanks
Family · Chiefland, FLNPI 1083254627
Payments from drug & device makers
Across 223 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$846
- AstraZeneca$603
- GSK$479
- Pfizer$402
- Lilly USA, LLC$366
- Grifols USA, LLC$285
- plus $939 from 14 others
What the payments were for
- Food & beverage$3,914100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 46 | $846 |
| AstraZeneca | 26 | $603 |
| GSK | 35 | $479 |
| Pfizer | 27 | $402 |
| Lilly USA, LLC | 22 | $366 |
| Grifols USA, LLC | 14 | $285 |
| Amgen | 17 | $240 |
| Exact Sciences | 8 | $178 |
| AbbVie | 5 | $85 |
| Merck | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Sanofi-aventis U.S. LLC | 3 | $60 |
| Boehringer Ingelheim | 2 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Amarin Pharma, Inc. | 1 | $22 |
| Alk-abello, Inc | 1 | $20 |
| Edwards Lifesciences | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$113
How this compares
$3,919 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $96,520 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $54,540 |
| OzempicSemaglutide | 22 | $30,167 |
| FarxigaDapagliflozin Propanediol | 16 | $24,169 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $22,311 |
| JanuviaSitagliptin Phosphate | 11 | $18,033 |
| JardianceEmpagliflozin | 14 | $16,079 |
| MounjaroTirzepatide | 11 | $14,728 |
| TrulicityDulaglutide | 13 | $12,780 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $7,087 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $5,529 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,993 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 158 | $4,508 |
| FenofibrateFenofibrate Nanocrystallized | 146 | $4,220 |
| Omeprazole | 191 | $3,566 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $402 | $96,52088 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $479 | $59,53261 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $603 | $49,68553 claims |
| Novo NordiskOzempic | $846 | $30,16722 claims |
| Lilly USA, LLCMounjaro, Trulicity | $366 | $27,50824 claims |
| MerckJanuvia | $83 | $18,03311 claims |
| Boehringer IngelheimJardiance | $44 | $16,07914 claims |
| AbbVieSynthroid | $85 | $2,82545 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Chiefland
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.